|
Q3 FY2026
As of Apr 30, 2026
|
Q2 FY2026
As of Jan 31, 2026
|
Q1 FY2026
As of Oct 31, 2025
|
Q4 FY2025
As of Jul 31, 2025
|
Q3 FY2025
As of Apr 30, 2025
|
Q2 FY2025
As of Jan 31, 2025
|
Q1 FY2025
As of Oct 31, 2024
|
Q4 FY2024
As of Jul 31, 2024
|
Q3 FY2024
As of Apr 30, 2024
|
Q2 FY2024
As of Jan 31, 2024
|
Q1 FY2024
As of Oct 31, 2023
|
Q4 FY2023
As of Jul 31, 2023
|
Q3 FY2023
As of Apr 30, 2023
|
Q2 FY2023
As of Jan 31, 2023
|
Q1 FY2023
As of Oct 31, 2022
|
Q4 FY2022
As of Jul 31, 2022
|
Q3 FY2022
As of Apr 30, 2022
|
Q2 FY2022
As of Jan 31, 2022
|
Q4 FY2021
As of Jul 31, 2021
|
Q1 FY2022
As of Oct 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | ||||||||||||||||||||
| Deposit for assets acquisition | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Other receivable | ||||||||||||||||||||
| Accounts receivable | ||||||||||||||||||||
| Other receivable -related party | ||||||||||||||||||||
| Employee advanced | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Non-Current Assets: | ||||||||||||||||||||
| Deposit for rent | ||||||||||||||||||||
| Deposit for license | ||||||||||||||||||||
| Operating lease right-of-use asset | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Current Liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Payroll liabilities - related party | ||||||||||||||||||||
| Deferred revenue and customer deposits | ||||||||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||||||||
| Accounts payable-related party | ||||||||||||||||||||
| Short term advance payable | ||||||||||||||||||||
| Due to related party | ||||||||||||||||||||
| Note payable, related party | ||||||||||||||||||||
| Operating lease liability - current portion | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Non-current Liability: | ||||||||||||||||||||
| Note payable, related party | ||||||||||||||||||||
| Operating lease liability | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Stockholders' Deficit | ||||||||||||||||||||
| Preferred stock: 50,000,000 authorized; $0.0001 par value, no shares issued and outstanding | ||||||||||||||||||||
| Common stock: 550,000,000 authorized; $0.0001 par value, 79,886,074 shares and 52,735,000 shares issued at April 30, 2026, and July 31, 2025, respectively | ||||||||||||||||||||
| Additional paid in capital | ||||||||||||||||||||
| Common stock subscriptions receivable-related party | ||||||||||||||||||||
| Treasury stock, at cost: 6,000,000 shares at October 31, 2024 and July 31, 2024, respectively | ||||||||||||||||||||
| Treasury stock, at cost: 6,000,000 shares at April 30, 2026, and July 31, 2025, respectively | ||||||||||||||||||||
| Common stock to be issued, 0 shares and 50,000 shares at April 30, 2026, and July 31, 2025, respectively | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total Stockholders' Deficit | ||||||||||||||||||||
| Total Liabilities and Stockholders' Equity (Deficit) | ||||||||||||||||||||
Loading...
